Surgery Partners (SGRY) Invested Capital (2013 - 2026)

Surgery Partners' Invested Capital history runs 14 years deep, the most recent figure standing at $3.1 billion for Q1 2026.

• In Q1 2026, Invested Capital fell 32.63% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (down 32.63% YoY), while the FY2025 annual figure was $4.5 billion, down 1.98% from the prior year.
• Invested Capital came in at $3.1 billion for Q1 2026 at Surgery Partners, down from $4.5 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $4.6 billion in Q4 2024 to a low of $2.6 billion in Q1 2022.
• A 5-year average of $3.8 billion and a median of $4.0 billion in 2025 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital jumped 83.01% in 2022 and sank 32.63% in 2026, its largest moves.
• Surgery Partners' Invested Capital stood at $4.3 billion in 2022, then gained by 3.08% to $4.4 billion in 2023, then grew by 3.69% to $4.6 billion in 2024, then dropped by 1.98% to $4.5 billion in 2025, then plunged by 32.11% to $3.1 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $3.1 billion, $4.5 billion, and $3.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison